BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AFSSI Sciences de la Vie - ECPv5.14.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:AFSSI Sciences de la Vie
X-ORIGINAL-URL:https://www.afssi.fr
X-WR-CALDESC:Events for AFSSI Sciences de la Vie
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180711
DTEND;VALUE=DATE:20180713
DTSTAMP:20260526T051025
CREATED:20180523T090449Z
LAST-MODIFIED:20180523T090449Z
UID:7268-1531267200-1531439999@www.afssi.fr
SUMMARY:Pharma AI & IOT 2018
DESCRIPTION:Pharma AI & IoT 2018 will provide insight into the current state of play in the EU & US and stimulate debate\, in a multi-stakeholder setting\, on the vital role of techonology impact in the sustainability of pharma and healthcare systems. \nBeyond a comprehensive outlook of key European market access policies\,  our speakers will outline the key recent developments in technology impact in pharma and healthcare in the EU and other international jurisdictions. \nBy attending this conference\, you will gain a comprehensive outlook on the key issues surrounding latest technologies that are being analysed towards the pharma and healthcare. This event will provide an important platform for stakeholders to discuss and share best practices in furthering technology development in pharma and healthcare. \nKEY THEMES:\n\nMarket overview and Analysis\nShaping the future of AI in Pharma\nAI for Precision Medicine\nHow AI technology can accelerate\, cheapen and De-Risk R&D\nMachine learning in patient stratification\, genomic analysis\, population investigation and real world data\nExploring R&D applications in machine learning\nScaling your business with implementation of AI\nAI to increase pharma innovation\nCyber Security is Critical in an Age of IoT and Healthcare Hacks\nBig Pharma\, Big Data – Big Deal? Yes\, Really!\nHow big data can revolutionise pharmaceutical R&D\nPromise and challenge of Big Data for Pharma\nPharma to open up big data for clinical trials\, analytics\nIoT could save billions in healthcare costs across the US and Europe\nDifferences that Internet of Things (IoT) Can Make to Healthcare\nDeveloping regulatory framework in advanced and developing markets – for Today & Tomorrow\nMoving beyond 5 years – What will the technology landscape look like?
URL:https://www.afssi.fr/event/pharma-ai-iot-2018/
LOCATION:Canary Riverside Plaza Hotel\, 46 Westferry Circus\, Canary Wharf\, London\, Royaume-Uni
CATEGORIES:Evénement filière
ATTACH;FMTTYPE=image/png:https://www.afssi.fr/wp-content/uploads/2018/05/Pharma-AI-IOT-2018-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180712
DTEND;VALUE=DATE:20180714
DTSTAMP:20260526T051025
CREATED:20180119T095449Z
LAST-MODIFIED:20180119T095449Z
UID:4346-1531353600-1531526399@www.afssi.fr
SUMMARY:13th International Conference on  Tissue Engineering and Regenerative Medicine
DESCRIPTION:Conferenceseries Ltd invites all the participants to its « 13th International Conference on Tissue Engineering and Regenerative Medicine » (TERM 2018) scheduled during July 12-13\, 2018 at Paris\, France. This gathering presents data with respect to front line improvements in every aspect of tissue designing\, undifferentiated cell look into regenerative prescription research including the science. This conference will be organized with in the theme Exploring new Ideas in regenerative medicine to treat degenerative diseases. \nConferenceseries Ltd through its open Access Initiative is resolved to make real and solid commitments to mainstream researchers. This conference expects to unite the Professors\, Researchers\, Business monsters and technocrats to give a universal gathering to the scattering of unique research comes about new thoughts and functional improvement and find progresses in the field of tissue building and regenerative solution.  It is the ideal opportunity for the tissue engineering and regenerative medicine ventures to meet up and anticipate the following 10 years of business triumphs inside these two areas. \nThe worldwide tissue designing and recovery is required to develop to about $20.8 billion in 2017 and $56.9 billion by 2019\, a compound yearly development rate (CAGR) of 22.3%.Europe hold the second place in the worldwide market in the field of tissue engineering and regenerative medicine. In Europe nations like UK and France are having great pieces of the overall industry in the field of tissue engineering and regenerative medicine.
URL:https://www.afssi.fr/event/13th-international-conference-tissue-engineering-regenerative-medicine/
LOCATION:Paris\, 72 Rue de Turbigo\, Paris\, France\, 75003
CATEGORIES:Evénement filière
ATTACH;FMTTYPE=image/jpeg:https://www.afssi.fr/wp-content/uploads/2018/01/event-paris2018-1.jpg
END:VEVENT
END:VCALENDAR